WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that in connection with its September 5, 2008 acquisition of Clarix LLC and in accordance with NASDAQ Marketplace Rule 4350, the company has granted shares of its common stock, in the form of stand-alone restricted stock units, or RSUs, as an inducement to the three founder employees and approximately 71 other employees of Clarix.
